Ethnicity Affects Drug Response

Published Online: Friday, April 1, 2005

An analysis of steroid therapy for asthma showed that it is less effective for African Americans, compared with Caucasians. The findings may explain why asthma oftentimes appears worse in this ethnicity group. The study involved 395 participants with asthma and 202 healthy participants who underwent different tests to evaluate their responsiveness to steroids. Reporting in Chest (February 2005), the researchers found that 27% of the participants with asthma were African American as were 52% of those without asthma. The researchers concluded that the amount of steroid required to block immune cell production was greater in African Americans, compared with Caucasians. The finding was consistent in both the asthma and nonasthma groups.

Latest Articles
Mylan has announced the US launch of clozapine orally disintegrating tablets, 25 mg and 100 mg, the generic version of Jazz Pharmaceutical’s FazaClo.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about some safeguards pharmacists can implement.
A pharmacy robber not only left his fingerprints behind at a pharmacy—he also dropped his wallet containing his identification as he made his escape.
Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).
Latest Issues